
@Mercerlab
383 posts



mRNA is an emerging class of biotherapeutics. We're collaborating with @LonzaGroup to pioneer a validated test for comprehensive analysis of mRNA products. The aim is to reduce analytical testing time, bringing them to market quicker. Read here: bit.ly/47TQFzU

BASE Facility, Australia's top mRNA provider, is creating a lab for clinical trial mRNA vaccines with $4.3M from the MRFF, $1M each from Sanofi, UQ, and $250K from the Queensland Government. The project ensures end-to-end capabilities for mRNA vaccine development. Watch more 👇




A dedicated lab will produce mRNA for clinical trials @AIBNatUQ's BASE facility. The next generation of mRNA vaccines and therapies will be built in Queensland, thanks to $4.3m from @healthgovau, #MRFF and contributions from #UQ @sanofi @QldGov👏 More: uq.au/BASE







New blog post: rrwick.github.io/2023/10/24/ont… I revisit the question of ONT-only accuracy for bacterial genomes, and things have improved a lot since I last looked at this about six months ago!







Curious about our use of @oxfordnanopore Technologies sequencing for mRNA vaccine quality testing at @BASEmRNA ? Check out the 'behind the paper' blog in Nature Genetics and Genomics Community written by @ Helen Gunter at @Mercerlab1 : gengenocommunity.springernature.com/posts/what-s-i…

Curious about our use of @oxfordnanopore Technologies sequencing for mRNA vaccine quality testing at @BASEmRNA ? Check out the 'behind the paper' blog in Nature Genetics and Genomics Community written by @ Helen Gunter at @Mercerlab1 : gengenocommunity.springernature.com/posts/what-s-i…







1/3 We are very excited to announce Dr @martinalexsmith as the new Director of the Ramaciotti Centre for Genomics starting January 2024 🎉 @ramacgenomics
